“While other VCs can tend to analyze themselves out of opportunities, Third Rock can see the hidden gem in science that’s not yet fully polished. As a firm, they create value by offering a stabilizing force when a company is building its infrastructure and operations.”
– Tom Hughes, Ph.D., President & Chief Executive Officer, Zafgen
At Third Rock we seek bold ideas and new frontiers that will pave the way for disruptive technologies and science which promise to dramatically improve the lives of patients.
We do that by collaborating with entrepreneurs to build, launch and operate our portfolio companies. Where needed, we may initially serve in key management roles - as we have with Agios, Constellation and Zafgen among others - in order to establish a solid foundation for the entrepreneur’s strategic vision, market knowledge, scientific expertise and/or social capital to accelerate the forward momentum of a company. We will also work with and support outstanding leadership teams that may already be in place as we have with Alnara. In all cases, we support portfolio companies in a range of areas, including:
Providing Strategic and Operational Leadership:
As successful business people and entrepreneurs with extensive operational backgrounds, we partner with portfolio companies across multiple functions to translate scientific innovation into the reality of breakthrough medical products.
Building Leadership and Culture
We recruit outstanding leadership at the management, board and advisory levels and nurture strong corporate cultures within our portfolio companies.
Offering R&D Insight
We work to develop a robust, real-world roadmap to advance novel products and devices, building upon our experience across the drug and medical device spectrum in multiple therapeutic areas.
Supporting Business Development Our team actively facilitates licensing and strategic opportunities with pharmaceutical and device companies by leveraging our track record of leading more than 500 collaborations, and creating more than $13 billion in value, along with our strong network of relationships with leaders at pharmaceutical companies worldwide. Collaborations with large life sciences companies are a key part of our unique strategy, as we can deliver innovation to their pipelines with new and exciting companies and in return build our companies in a more capital efficient manner.
